Payment overview · 2025
General Payments
$71.51
3 reported records · 3 companies
Healthcare provider profile · identity verified
Steven Howard Turner, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · GARNER, NC · NPI 1861506735
Verified facts
What the public records show
CMS Open Payments records show Steven Howard Turner, M.D. received $71.51 in general payments during 2025 across 3 reported records.
Boston Scientific Corporation accounted for 40.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $29.04 | 40.6% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $27.84 | 38.9% | 1 | 2025 |
| Sonex Health, Inc. | Unresolved — no canonical attribution shown | $14.63 | 20.5% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $71.51 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Artisan Normalized: artisan |
Device | Boston Scientific Corporation | $29.04 | 1 | 2025 |
Source payment records
|
|||||
| ETERNA Normalized: eterna |
Device | Abbott Laboratories | $27.84 | 1 | 2025 |
Source payment records
|
|||||
| SX-ONE MICROKNIFE Normalized: sx one microknife |
Device | Sonex Health, Inc. | $14.63 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 849 | 252 |
| Losartan Potassium | Losartan Potassium | 633 | 170 |
| Amlodipine Besylate | Amlodipine Besylate | 614 | 177 |
| Levothyroxine Sodium | Levothyroxine Sodium | 517 | 145 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 495 | 150 |
| Omeprazole | Omeprazole | 457 | 118 |
| Lisinopril | Lisinopril | 370 | 103 |
| Simvastatin | Simvastatin | 280 | 73 |
| Hydrochlorothiazide | Hydrochlorothiazide | 258 | 77 |
| Metformin Hcl Er | Metformin Hcl | 214 | 64 |
| Gabapentin | Gabapentin | 211 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 200 | 58 |
| Tamsulosin Hcl | Tamsulosin Hcl | 198 | 67 |
| Pantoprazole Sodium | Pantoprazole Sodium | 191 | 57 |
| Alprazolam | Alprazolam | 183 | 36 |
| Pravastatin Sodium | Pravastatin Sodium | 169 | 47 |
| Trazodone Hcl | Trazodone Hcl | 167 | 44 |
| Furosemide | Furosemide | 162 | 51 |
| Sertraline Hcl | Sertraline Hcl | 157 | 44 |
| Glipizide Er | Glipizide | 155 | 44 |
| Meloxicam | Meloxicam | 155 | 39 |
| Zolpidem Tartrate | Zolpidem Tartrate | 142 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 140 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 136 | 40 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 135 | 42 |
| Allopurinol | Allopurinol | 127 | 36 |
| Tramadol Hcl | Tramadol Hcl | 123 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 121 | 33 |
| Metformin Hcl | Metformin Hcl | 116 | 34 |
| Ozempic | Semaglutide | 112 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 110 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 110 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 107 | 34 |
| Fluticasone Propionate | Fluticasone Propionate | 105 | 38 |
| Prednisone | Prednisone | 105 | 69 |
| Montelukast Sodium | Montelukast Sodium | 102 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 83 | 22 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 22 |
| Famotidine | Famotidine | 79 | 24 |
| Finasteride | Finasteride | 76 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 75 | 60 |
| Fluoxetine Hcl | Fluoxetine Hcl | 74 | 23 |
| Azithromycin | Azithromycin | 70 | 52 |
| Celecoxib | Celecoxib | 63 | 17 |
| Bupropion Xl | Bupropion Hcl | 57 | 21 |
| Lovastatin | Lovastatin | 57 | 15 |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | 16 |
| Eliquis | Apixaban | 56 | 13 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 55 | 14 |
| Carvedilol | Carvedilol | 54 | 18 |
| Potassium Chloride | Potassium Chloride | 54 | 16 |
| Atenolol | Atenolol | 48 | suppressed |
| Lorazepam | Lorazepam | 48 | 16 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 46 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 43 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 42 | 35 |
| Ezetimibe | Ezetimibe | 40 | 11 |
| Valacyclovir | Valacyclovir Hcl | 39 | 26 |
| Spironolactone | Spironolactone | 38 | suppressed |
| Clonazepam | Clonazepam | 37 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 37 | 11 |
| Methylprednisolone | Methylprednisolone | 37 | 32 |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 26 |
| Tizanidine Hcl | Tizanidine Hcl | 35 | 16 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 34 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 33 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 33 | 12 |
| Jardiance | Empagliflozin | 32 | 11 |
| Pregabalin | Pregabalin | 32 | suppressed |
| Diazepam | Diazepam | 31 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 30 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 29 | suppressed |
| Fluconazole | Fluconazole | 29 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 29 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 29 | 16 |
| Valsartan | Valsartan | 29 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 28 | 12 |
| Paxlovid | Nirmatrelvir/Ritonavir | 28 | 28 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | 19 |
| Ramipril | Ramipril | 27 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 26 | suppressed |
| Amoxicillin | Amoxicillin | 25 | 20 |
| Clonidine Hcl | Clonidine Hcl | 25 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Ketoconazole | Ketoconazole | 24 | 17 |
| Mirtazapine | Mirtazapine | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 23 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Ibuprofen | Ibuprofen | 22 | 11 |
| Verapamil Er | Verapamil Hcl | 22 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 20 | suppressed |
| Cephalexin | Cephalexin | 19 | 11 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 19 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 18 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 18 | suppressed |
| Levofloxacin | Levofloxacin | 17 | 15 |
| Raloxifene Hcl | Raloxifene Hcl | 17 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 16 | suppressed |
| Felodipine Er | Felodipine | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Glipizide | Glipizide | 14 | suppressed |
| Nabumetone | Nabumetone | 14 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 13 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | 11 |
| Tresiba Flextouch U-200 | Insulin Degludec | 13 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 12 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 12 | suppressed |
| Bystolic | Nebivolol Hcl | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 12 | suppressed |
| Tekturna | Aliskiren Hemifumarate | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 11 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Eszopiclone | Eszopiclone | 11 | suppressed |
| Etodolac | Etodolac | 11 | suppressed |
| Nitroglycerin | Nitroglycerin | 11 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $71.51 · 3 records | Boston Scientific Corporation | Artisan, ETERNA, SX-ONE MICROKNIFE | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error